Indiegogo is committed to accessibility. If you have difficulty using our site, please contact support@indiegogo.com for assistance or view our accessibility notice by clicking here

🔆 Staples' 5-in-1 Productivity Light is LIVE. Back it now.

This campaign is closed

Biomagna Pro Quit Smoking

The first PEMF device (Pulsed Electromagnetic Field) for smoking cessation.

Biomagna Pro Quit Smoking

The first PEMF device (Pulsed Electromagnetic Field) for smoking cessation.

1 Campaign |

Wellington, United States

$2,256 USD 4 backers

75% of $3,000 Flexible Goal Flexible Goal

Story

FAQ

Updates 1

Discussion 12

Prototype

The project team has a working demo, not the final product. Their ability to begin production may be affected by product development or financial challenges.

Learn More →

Concept Prototype Production Shipping

INTRODUCING

The latest in smoking cessation technology

A Biomagna project - A company with more than 20 years helping people to quit smoking

Smoking & Tobacco Use: Data and Statistics

How Much Does Smoking Cost?

First prototypes

What is PEMF Technology?

Pulsed Electro-Magnetic Field (PEMF) therapy uses technology to stimulate and exercise cells to help resolve cellular dysfunction and to support overall wellness.

Devices that utilize PEMF technology emit electromagnetic waves at different frequencies in order to stimulate and encourage your brain’s natural recovery process.

Biomagna Pro Quit Smoking is the first PEMF device with specific frecuencies to help you to quit smoking.

How it works?

How to use it?

Studies on PMF technology and addictions

Reduces Nicotine Cue Craving

Xingbao Li, Karen J. Hartwell, Max Owens, Todd LeMatty, Jeffrey J. Borckardt, Colleen, Hanlon, Kathleen T. Brady, and Mark S. George. BIOL PSYCHIATRY 2013.

Reduces cigarette craving and consumption

Revital Amiaz, Dino Levy, Dana Vainiger, Leon Grunhaus; Abraham Zangen. Psychiatry Clinic, Sheba Medical Center, Tel-Hashomer, Depar tment of Neurobiology, The Weizmann Institute of Science, Rehovot, Israel and The Jerusalem MHC, Israel Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.